Resultats de la cerca - Takuji Okusaka

Refinar resultats
  1. 1
    Immunotherapy for hepatocellular carcinoma: current status and future perspectives

    Immunotherapy for hepatocellular carcinoma: current status and future perspectives per Takuji Okusaka, Masafumi Ikeda

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines

    Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines per Takuji Okusaka, Junji Furuse

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Phase II study of S-1 in patients with advanced biliary tract cancer

    Phase II study of S-1 in patients with advanced biliary tract cancer per Hideki Ueno, Takuji Okusaka, Masafumi Ikeda, Yoriko Takezako, Chigusa Morizane

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    A National Survey to Systematically Identify Factors Associated With Oncologists’ Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions?

    A National Survey to Systematically Identify Factors Associated With Oncologists’ Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions? per Masanori Mori, Chikako Shimizu, Asao Ogawa, Takuji Okusaka, Saran Yoshida, Tatsuya Morita

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Chemotherapy for hepatocellular carcinoma: current status and future perspectives

    Chemotherapy for hepatocellular carcinoma: current status and future perspectives per Masafumi Ikeda, Chigusa Morizane, Makoto Ueno, Takuji Okusaka, Hiroshi Ishii, Junji Furuse

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    New developments in systemic therapy for advanced biliary tract cancer

    New developments in systemic therapy for advanced biliary tract cancer per Chigusa Morizane, Makoto Ueno, Masafumi Ikeda, Takuji Okusaka, Hiroshi Ishii, Junji Furuse

    Publicat 2018
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)

    Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT) per Junki Mizusawa, Chigusa Morizane, Takuji Okusaka, Hiroshi Katayama, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses

    Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses per Toshiyuki Tamai, Seiichi Hayato, Seiichiro Hojo, Takuya Suzuki, Takuji Okusaka, Kenji Ikeda, Hiromitsu Kumada

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma

    Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma per Shunsuke Kondo, Hideki Ueno, Hiroko Hosoi, Junichiro Hashimoto, Chigusa Morizane, Fumiaki Koizumi, Kenji Tamura, Takuji Okusaka

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Phase <scp>II</scp> study of <scp>FOLFIRINOX</scp> for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer

    Phase <scp>II</scp> study of <scp>FOLFIRINOX</scp> for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer per Takuji Okusaka, Masafumi Ikeda, Akira Fukutomi, Tatsuya Ioka, Junji Furuse, Shinichi Ohkawa, Hiroyuki Isayama, Narikazu Boku

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Elevated Serum Interleukin-6 Levels in Patients with Pancreatic Cancer

    Elevated Serum Interleukin-6 Levels in Patients with Pancreatic Cancer per Shoichi Okada, Takuji Okusaka, Hiroshi Ishii, Akiko Kyogoku, Masayoshi Yoshimori, Naoko Kajimura, Ken Yamaguchi, Tadao Kakizoe

    Publicat 1998
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future

    Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future per Masafumi Ikeda, Shuichi Mitsunaga, Izumi Ohno, Yusuke Hashimoto, Hideaki Takahashi, Kazuo Watanabe, Kumiko Umemoto, Takuji Okusaka

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  13. 13
    Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer

    Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer per Takuji Okusaka, Yukako Ιtο, Hideki Ueno, Masafumi Ikeda, Yoriko Takezako, Chigusa Morizane, Yoshikazu Kagami, Hiroshi Ikeda

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Japanese phase I study of<scp>GC</scp>33, a humanized antibody against glypican‐3 for advanced hepatocellular carcinoma

    Japanese phase I study of<scp>GC</scp>33, a humanized antibody against glypican‐3 for advanced hepatocellular carcinoma per Masafumi Ikeda, Shinichi Ohkawa, Takuji Okusaka, Shuichi Mitsunaga, Satoshi Kobayashi, Chigusa Morizane, Ikue Suzuki, S. Yamamoto, Junji Furuse

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

    Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials per Juan W. Valle, Junji Furuse, Mark Jitlal, Sandy Beare, Nobumasa Mizuno, Harpreet Wasan, John Bridgewater, Takuji Okusaka

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  16. 16
    Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection

    Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection per Hiroshi Ishii, Shuichi Okada, Haruhiko Nose, Takuji Okusaka, Masayoshi Yoshimori, Tadatoshi Takayama, T Kosuge, Susumu Yamasaki, Michiie Sakamoto, S Hirohashi

    Publicat 1996
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

    A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT) per Kohei Nakachi, Masaru Konishi, Masafumi Ikeda, Junki Mizusawa, Junko Eba, Takuji Okusaka, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society

    Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society per Takuji Okusaka, Satoaki Nakamura, Masahiro Yoshida, Masayuki Kitano, Katsuhiko Uesaka, Yoshinori Ito, Junji Furuse, Keiji Hanada, Kazuichi Okazaki

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  19. 19
    Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506

    Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506 per Hiroshi Ishii, J. Furuse, Narikazu Boku, Takuji Okusaka, Masafumi Ikeda, S. Ohkawa, Akira Fukutomi, Yasuo Hamamoto, K. Nakamura, Hiroyuki Fukuda

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies

    Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies per Tal Grenader, Stephen Nash, Yevgeni Plotkin, Junji Furuse, Nobumasa Mizuno, Takuji Okusaka, Harpreet Wasan, Juan W. Valle, John Bridgewater

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: